AVE avecho biotechnology limited

Newsletter, page-9

  1. 123 Posts.
    lightbulb Created with Sketch. 6
    GC

    Firstly i think its a good idea to get a list of questions before hand so hopefully all our queries will be answered on the day so Ross can get a feel of what the share holders want answered so keep them coming. I would like less time on reciting the newsletter as im sure that everyone thats bothers to call up has no doubt read the the letter numerous times and more time allocated to questions.

    My main questions would be a continuation of HT in regards to a successful oxyC results. I would like a frank response of:
    Are we talking to pharma about a deal?
    If we are, what is there response?
    What is chance of doing deal after next results?
    If no deal, what else do we need to do?
    How long would further testing take?
    How expensive will further testing be and how do we pay for it as well as completing trials for oxyM.

    All this may be covered in the newsletter but i just think at 1.5c management can at least show us the decency on where exactly we are with our hopefully successful oxy C results
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $11.10M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
44 34619260 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 8218985 6
View Market Depth
Last trade - 07.32am 07/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.